Chronic Venous Insufficiency (CVI)

Introduction: Vascular diseases are among the most widespread diseases in the wrold. Among them, the chronic venous insufficiency (CVI) of the lower limbs represents one of the diseases with higher…

Muscle, Bone & Joint Pain

Muscle, Bone and Joint Pain/Muscle Relaxants: Cyclobenzaprine: Cyclobenzaprine is a muscle relaxant. It works by blocking nerve impulses (or pain sensations) that are sent to your brain. Cyclobenzaprine is used…

Treatment of Alzheimer’s disease

Introduction: The FDA has approved two types of medications for the maangement of Alzheimer's disease: cholinesterase inhibitors and the NMDA-type glutamate receptor inhibitor memantine. These therapies serve to alleviate cognitive…

Ypatent® – Patent Prosecution Services

Ypatent® provides strategic patent services for innovators, startups, and companies nationwide. Representation includes biotechnology, pharmaceutical, and general patent prosecution. For inquiries or to discuss a potential matter, contact: Telephone:(813) 419-2296 …

Ypatent® – Patentability & FTO Analysis

Patent Services Offered: Strategic patent portfolio development Biotechnology and pharmaceutical patent prosecution Freedom-to-operate and clearance analysis Patent due diligence for transactions and investment Patent validity and infringement analysis Contact Ypatent®…

Ypatent® Services

Ypatent® provides strategic patent services for innovators, startups, and companies nationwide. Representation includes biotechnology, pharmaceutical, and general patent prosecution. For inquiries or to discuss a potential matter, contact: Telephone:(813) 419-2296 …

James Rogers Biography

Author Biography: is a patent attorney and former patent examiner with the United States Patent and Trademark Office. Previous to his work as a patent examiner, James was in house counsel…

Biosimilars

The pipeline of follow-on (biosimilar) products in developmetn includes nearly 800 biosimilars. See Biosimilarspipeline Guidance for Industry: Clinical Pharmacology Data to Support a Demonstration of Biosimilarity to a Reference Product, May…

Expedited Drug Approval

Guidance for industry Expedited Programs for Serious Conditions – Drugs and Biologics (May 2014) The FDA has several programs which are intended to facilitate and expedite development and review of…